RA Capital Management’s Latigo Biotherapeutics LTGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$88.6M Buy
+5,302,933
New +$112M 0.89% 24

Other funds holding LTGO

RA Capital Management's LTGO Position: Q3 2026 in Review

RA Capital Management opened a new position in Latigo Biotherapeutics (LTGO) in Q3 2026: 5,302,933 shares worth $88.6M. The stake represents 0.89% of the portfolio and ranks #24 among its holdings.

58 funds tracked by Wall St. Rank hold LTGO as of Q3 2026.

  • RA Capital Management held 5,302,933 shares of Latigo Biotherapeutics worth $88.6M as of Q3 2026.
  • Latigo Biotherapeutics was a new RA Capital Management position in Q3 2026.
  • Latigo Biotherapeutics made up 0.89% of RA Capital Management's portfolio in Q3 2026, its #24 holding.
  • 58 funds tracked by Wall St. Rank held Latigo Biotherapeutics as of Q3 2026.

Based on RA Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.